showed efficacy in in vitro studies; however, to date,<br/>these treatments have not undergone any randomized<br/>animal or human clinical trials, which limit their<br/>practical applicability in the current pandemic (7, 9,<br/>19-21).<br/><br/>The present comprehensive review describes the<br/>various features of SARS-CoV-2/COVID-19 causing<br/>the current disease outbreaks and advances in<br/>diagnosis and developing vaccines and therapeutics.<br/>It also provides a brief comparison with the earlier<br/>SARS and MERS CoVs, the veterinary perspective<br/>of CoVs and this emerging novel pathogen, and an<br/>evaluation of the zoonotic potential of similar CoVs<br/>to provide feasible One Health strategies for the<br/>management of this fatal virus (22-367).<br/><br/>THE VIRUS (SARS-CoV-2)<br/><br/>Coronaviruses are positive-sense RNA viruses<br/>having an extensive and promiscuous range of<br/>natural hosts and affect multiple systems (23, 24).<br/>Coronaviruses can cause clinical diseases in humans<br/>that may extend from the common cold to more<br/>severe respiratory diseases like SARS and MERS<br/>(17, 279). The recently emerging SARS-CoV-2 has<br/>wrought havoc in China and caused a pandemic<br/><br/>â€˜nation in fi Idwid lati leadi